Inflammatory Bowel Disease (IBD) is a complex and chronic condition that affects millions of people worldwide. It’s a debilitating illness that affects the digestive system and causes inflammation and damage to the gut lining. Despite significant advancements in medicine, IBD continues to be a challenge for patients, caregivers, and medical professionals.

However, two MedcoVet clinicians have joined forces to break new ground in the treatment of IBD. Cathy Symons, a clinician, approached the team at MedcoVet with a question about a new treatment option for IBD. MedcoVet then connected her with Dr. Ron Hirschberg, a seasoned expert in the field and a leading author on IBD.

The result of their collaboration is a cutting-edge protocol for treating IBD using the Luma, a state-of-the-art medical device. The Luma is a non-invasive and pain-free device that uses light therapy to heal and regenerate damaged tissues. The new protocol combines the Luma’s therapeutic properties with Dr. Hirschberg’s extensive knowledge of IBD to provide patients with a new and effective treatment option.

The new protocol is designed to target the root cause of IBD, which is inflammation in the gut. The Luma’s light therapy works by stimulating the cells in the gut to regenerate and heal, reducing inflammation and promoting overall gut health. This results in reduced symptoms, improved quality of life, and a better chance of remission for patients with IBD.

It’s an exciting development in the field of IBD and a step forward in providing patients with more effective and non-invasive treatment options. We hope that this new protocol will bring relief and comfort to those who suffer from IBD and improve their overall quality of life.

In conclusion, the collaboration between Cathy Symons and Dr. Ron Hirschberg has resulted in a new protocol for treating IBD using the Luma. The new protocol provides patients with a non-invasive, pain-free, and effective treatment option that targets the root cause of IBD, reducing inflammation and promoting gut health. We look forward to seeing the positive impact that this new protocol will have on the lives of those who suffer from IBD.